CA 125 testing is usually recommended for women who are at high risk for ovarian cancer or who have already been diagnosed with the disease. It is not typically used for routine screening in women who do not have symptoms or a high-risk profile. The test is often administered in conjunction with other diagnostic tools, such as ultrasound and CT scans.